---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-25-000070"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:37:12.650761+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# GeneDx Q1 revenue $87.1M, exome/genome revenue up 62% YoY; raises FY 2025 guidance

## Summary
- Q1 exome/genome revenue $71.4M (+62% YoY); total revenue $87.1M (+42% YoY).
- Adjusted net income $7.7M vs loss of $8.0M a year ago; GAAP net loss $6.5M.
- Announced plans to acquire Fabric Genomics; no deal value disclosed.
- Raised FY 2025 revenue guidance to $360-375M; reaffirms exome/genome growth of at least 30%.
- Adjusted gross margin improved to 69% from 61% YoY; cash $160.2M at quarter-end.

## SEC filing metadata
- accession: 0001818331-25-000070
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/0001818331-25-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/wgs-20250430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-25-000070
- JSON: https://secwatch.observer/filing/0001818331-25-000070.json
- Plain text: https://secwatch.observer/filing/0001818331-25-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.